Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,008 INR | -1.97% | +0.20% | +24.20% |
Apr. 09 | Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit | MT |
Mar. 27 | NATCO Pharma Limited Announces Board Appointments | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.20% | 2.21B | |
+25.83% | 661B | |
+26.90% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.87% | 231B | |
+5.17% | 200B | |
-8.83% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Transcript : NATCO Pharma Limited, Q2 2024 Earnings Call, Nov 15, 2023